SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

2.

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

3.

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

4.

A new drug delivery system may help patients with a rare eye cancer

5.

Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot